Estradiol induces osteoprotegerin expression by human dental pulp cells

Area of Science:

• Endocrinology
• Cell Biology
• Dental Research

Background:

• Estrogen deficiency correlates with heightened inflammation and periapical bone resorption.
• Osteoprotegerin (OPG) and receptor activator of nuclear factor κB ligand (RANKL) are key regulators of bone metabolism.

Purpose of the Study:

• To investigate the impact of estrogen on OPG and RANKL expression in human dental pulp cells (HDPs).
• To elucidate the intracellular mechanisms underlying estrogen's effects on these factors.

Main Methods:

• HDPs were treated with varying concentrations of estradiol.
• Analysis of OPG and RANKL at mRNA and protein levels.
• Utilized estrogen receptor (ER) inhibitors, ER-α and ER-β agonists, estradiol-BSA conjugate, GPR30 agonist, ERK inhibitor, and p38 inhibitor.

Main Results:

• Estradiol dose-dependently upregulated OPG mRNA and protein expression in HDPs.
• Estradiol did not affect RANKL expression.
• OPG upregulation was mediated by a membrane receptor (GPR30) and involved ERK and p38 signaling pathways, independent of classical ERs.

Conclusions:

• Estradiol regulates OPG expression in HDPs through a non-classical pathway involving membrane receptors.
• The balance between ERK and p38 signaling pathways is critical for this regulation.
• Findings suggest novel therapeutic targets for managing estrogen deficiency-related bone loss.